SMALL CELL LUNG-CANCER (SCLC) CHEMOTHERAPY WITH CYTOXAN AND METHOTREXATE (CM) AS PRIMARY SYSTEMIC TREATMENT

被引：0
|
作者：
DIEKAMP, U [1 ]
机构：
[1] UNIV ILLINOIS,CHICAGO,IL 60680
来源：
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1980年 / 21卷 / MAR期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：462 / 462
页数：1
相关论文
共 50 条
  • [31] Result of chemotherapy in small cell lung cancer (SCLC)
    Gamaz, Bensaou M.
    Kamel, Bouzid
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S813 - S813
  • [32] Evolution of chemotherapy for small cell lung cancer (SCLC).
    Vaslamatzis, M
    Alexopoulos, C
    Patila, E
    Filadetaki, V
    Rontoyanni, D
    ANNALS OF ONCOLOGY, 2000, 11 : 121 - 121
  • [33] FAILURE OF HIGH-DOSE METHOTREXATE (HDMTX) AS CNS PROPHYLAXIS IN SMALL CELL LUNG-CANCER (SCLC)
    KILLEN, J
    HOTH, D
    LOKEY, JL
    SMITH, L
    SMITH, F
    WOOLLEY, P
    MACDONALD, J
    SCHEIN, P
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 506 - 506
  • [34] COMPLETE RESPONSES OBTAINED BY INTENSIVE CHEMOTHERAPY IN PATIENTS WITH SMALL-CELL LUNG-CANCER (SCLC)
    SCULIER, JP
    KLASTERSKY, J
    BECQUART, D
    VANDERMOTEN, G
    ROCMANS, P
    THIRIAUX, J
    LONGEVAL, E
    RAVEZ, P
    LIBERT, P
    MOMMEN, P
    BULLETIN EUROPEEN DE PHYSIOPATHOLOGIE RESPIRATOIRE-CLINICAL RESPIRATORY PHYSIOLOGY, 1986, 22 : S116 - S116
  • [35] MENINGEAL CARCINOMATOSIS (MC) FOLLOWING INTENSIVE COMBINATION CHEMOTHERAPY FOR SMALL CELL LUNG-CANCER (SCLC)
    LEVI, J
    ARONEY, R
    DALLEY, D
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 187 - 187
  • [36] CFU-C COUNT DURING CHEMOTHERAPY FOR SMALL-CELL LUNG-CANCER (SCLC)
    POSTMUS, PE
    DEVRIES, EGE
    MULDER, NH
    VANLUYN, M
    HALIE, MR
    SLUITER, HJ
    EUROPEAN JOURNAL OF RESPIRATORY DISEASES, 1982, 63 : 142 - 142
  • [37] INTERDIGITATING VERSUS CONCURRENT CHEMOTHERAPY AND RADIOTHERAPY FOR LIMITED SMALL-CELL LUNG-CANCER (SCLC)
    KOMAKI, R
    SHIN, D
    GLISSON, B
    FOSSELLA, F
    MURPHY, W
    GARDEN, A
    OSWALD, M
    HONG, W
    ROTH, J
    PETERS, L
    ELLERBROEK, N
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1993, 27 : 188 - 188
  • [38] COMPARISON OF MYELOTOXICITY RELATING TO 2 CHEMOTHERAPY REGIMENS FOR SMALL-CELL LUNG-CANCER (SCLC)
    FISHWICK, D
    LOUGHNEY, E
    LIND, M
    CALVERT, H
    CORRIS, PA
    GIBSON, GJ
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 147 (04): : A749 - A749
  • [39] HEXAMETHYLMELAMINE (ALTRETAMINE) IN SMALL-CELL LUNG-CANCER (SCLC)
    COMIS, RL
    CANCER TREATMENT REVIEWS, 1991, 18 : 85 - 90
  • [40] RANDOMIZED TRIAL OF PLANNED VERSUS AS REQUIRED CHEMOTHERAPY IN SMALL-CELL LUNG-CANCER (SCLC)
    SOUHAMI, RL
    EARL, H
    ASH, CM
    SPIRO, SG
    GEDDES, D
    HARPER, PG
    BRITISH JOURNAL OF CANCER, 1987, 56 (02) : 224 - 224
12345